Literature DB >> 27668809

Kawasaki Disease at 50 Years.

Ezra Cohen1, Robert Sundel1.   

Abstract

Importance: Kawasaki disease (KD) is the most recognized vasculitis of childhood. The condition's characteristic high fever, rash, mucositis, conjunctivitis, lymphadenopathy, and extremity changes are superficially unexceptional, and resolve spontaneously within a mean of 12 days. It is the acuity and the potential for life-changing damage to the coronary arteries that distinguish KD from conditions that mimic it and exemplify the unique aspects and challenges of vascular inflammation in children. Observations: Although KD is an orphan disease, its role as a leading cause of acquired heart disease in children has led to significant efforts to determine its etiology, optimize diagnosis, and customize treatment according to individuals' needs. The result is that KD can now be controlled without sequelae in more than 95% of cases. Furthermore, advances in stratifying patients according to measurable risk factors allow therapy to be personalized in increasingly effective ways. High-risk patients, such as infants younger than 6 months, those with early evidence of coronary artery dilatation, and those with extreme abnormalities in laboratory test results, are often identified at presentation. This early identification allows them to be treated with corticosteroids in addition to intravenous immunoglobulin to improve their outcomes. Children with similar findings on laboratory tests and echocardiography may be treated based on algorithms for managing "incomplete KD" despite falling short of fulfilling classic diagnostic criteria. Children who do not respond to intravenous immunoglobulin are the focus of trials to minimize the duration of inflammation and thereby protect their coronary arteries in ways never before considered. Conclusions and Relevance: Kawasaki disease is a hybrid condition at the junction of infectious diseases, immunology, rheumatology, and cardiology. Rather than being left an orphan disease, KD is bringing disciplines together to identify its genetic, pathophysiological, and hemodynamic features. In turn, this work promises to shed light on many other inflammatory conditions as well.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27668809     DOI: 10.1001/jamapediatrics.2016.1446

Source DB:  PubMed          Journal:  JAMA Pediatr        ISSN: 2168-6203            Impact factor:   16.193


  10 in total

1.  Prevalence and characteristics of arthritis in Kawasaki disease: a Chinese cohort study.

Authors:  Yu Peng; Xiaohui Liu; Zhao Duan; Yuhong Deng; Sufen Cai; Zhi Wang; Kun Xu; Hui Kang; Man Jiang; Lin Li; Yulan Zhou; Zheng Zou
Journal:  Clin Exp Med       Date:  2019-02-06       Impact factor: 3.984

2.  Analysis of Circular RNAs in the Coronary Arteries of Patients with Kawasaki Disease.

Authors:  Young-Kook Kim
Journal:  J Lipid Atheroscler       Date:  2019-03-29

Review 3.  Is Kawasaki disease an infectious disorder?

Authors:  Anne H Rowley
Journal:  Int J Rheum Dis       Date:  2017-11-03       Impact factor: 2.454

4.  Incomplete Kawasaki disease in Egypt.

Authors:  Hala M Agha; Hala S Hamza
Journal:  Glob Cardiol Sci Pract       Date:  2017-10-31

5.  Distinguishing Kawasaki Disease from Febrile Infectious Disease Using Gene Pair Signatures.

Authors:  Jiayong Zhong; Qingsheng Huang; Yanfei Wang; Huan Gao; Hongling Jia; Jun Fan; Huiying Liang
Journal:  Biomed Res Int       Date:  2020-04-26       Impact factor: 3.411

Review 6.  Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison.

Authors:  Chetan Sharma; Madhusudan Ganigara; Caroline Galeotti; Joseph Burns; Fernando M Berganza; Denise A Hayes; Davinder Singh-Grewal; Suman Bharath; Sujata Sajjan; Jagadeesh Bayry
Journal:  Nat Rev Rheumatol       Date:  2021-10-29       Impact factor: 20.543

7.  Kawasaki Disease Hospitalizations in the United States 2016-2020: A Comparison of Before and During the Coronavirus Disease 2019 Era.

Authors:  Timothy T Phamduy; Sharon Smith; Katherine W Herbst; Paul T Phamduy; Michael Brimacombe; Alexander H Hogan; Juan C Salazar; Jesse Sturm
Journal:  Pediatr Infect Dis J       Date:  2021-11-01       Impact factor: 3.806

8.  Multisystem Inflammatory Syndrome in Children: Unique Disease or Part of the Kawasaki Disease Spectrum?

Authors:  Caterina Matucci-Cerinic; Roberta Caorsi; Alessandro Consolaro; Silvia Rosina; Adele Civino; Angelo Ravelli
Journal:  Front Pediatr       Date:  2021-06-04       Impact factor: 3.418

9.  Influence of Latitude on the Prevalence of Kawasaki Disease: A Retrospective Cohort Study from the Taiwan National Health Insurance Database and Review of the Literature.

Authors:  Chaw-Liang Chang; Chih-Shung Wong; Yi-Chen Yang; Nan-Chang Chiu
Journal:  Int J Environ Res Public Health       Date:  2018-04-25       Impact factor: 3.390

10.  Serum Levels of Syndecan-1 in Patients With Kawasaki Disease.

Authors:  Li Luo; Siqi Feng; Yao Wu; Ya Su; Fengchuan Jing; Qijian Yi
Journal:  Pediatr Infect Dis J       Date:  2019-01       Impact factor: 2.129

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.